Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers

An early first full-time pregnancy substantially reduces the risk of developing breast cancer later in life. Extensive studies indicate that this protective effect is mediated by the pregnancy hormone human chorionic gonadotrophin (hCG). METHODS: In this proof-of-concept study 33 women with a BRCA m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Cancer Prev
Huvudupphovsmän: Depypere, Herman, Su, Yanrong, Dang, Nhi, Poppe, Bruce, Stanczyk, Frank, Janssens, Jaak, Russo, Jose
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2021
Ämnen:
Breast Cancer
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011504/
https://ncbi.nlm.nih.gov/pubmed/33720054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CEJ.0000000000000664
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk